DE10196025T1 - Dermatologische Verwendung und ein dermatologisches Präparat - Google Patents

Dermatologische Verwendung und ein dermatologisches Präparat

Info

Publication number
DE10196025T1
DE10196025T1 DE10196025T DE10196025T DE10196025T1 DE 10196025 T1 DE10196025 T1 DE 10196025T1 DE 10196025 T DE10196025 T DE 10196025T DE 10196025 T DE10196025 T DE 10196025T DE 10196025 T1 DE10196025 T1 DE 10196025T1
Authority
DE
Germany
Prior art keywords
dermatological
preparation
dermatological preparation
dermatological use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10196025T
Other languages
German (de)
English (en)
Inventor
Pekka Heino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEINO, PEKKA, HELSINKI, FI
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of DE10196025T1 publication Critical patent/DE10196025T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DE10196025T 2000-04-06 2001-02-05 Dermatologische Verwendung und ein dermatologisches Präparat Withdrawn DE10196025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Publications (1)

Publication Number Publication Date
DE10196025T1 true DE10196025T1 (de) 2003-03-13

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10196025T Withdrawn DE10196025T1 (de) 2000-04-06 2001-02-05 Dermatologische Verwendung und ein dermatologisches Präparat

Country Status (14)

Country Link
US (2) US20030144359A1 (OSRAM)
EP (1) EP1274416A1 (OSRAM)
JP (1) JP2003530349A (OSRAM)
AU (1) AU2001235506A1 (OSRAM)
CA (1) CA2405425A1 (OSRAM)
CH (1) CH695983A5 (OSRAM)
DE (1) DE10196025T1 (OSRAM)
DK (1) DK200201483A (OSRAM)
ES (1) ES2193003B1 (OSRAM)
FI (1) FI107018B (OSRAM)
GB (1) GB2377380B (OSRAM)
NO (1) NO20024810L (OSRAM)
SE (1) SE0202886L (OSRAM)
WO (1) WO2001076589A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
JP2007505837A (ja) * 2003-09-15 2007-03-15 オードウェイ リサーチ インスティテュート 甲状腺ホルモンアナログおよび新脈管形成における使用の方法
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
US9220788B2 (en) 2009-06-17 2015-12-29 Nanopharmaceuticals Llc Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
JP2010513526A (ja) 2006-12-22 2010-04-30 シーエルエフ メディカル テクノロジー アクセラレーション プログラム インコーポレイテッド 甲状腺ホルモン類縁体、拮抗剤および製剤のためのナノ粒子及び重合体製剤ならびにその使用
WO2010075332A1 (en) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Small molecule ligands of the integrin rgd recognition site and methods of use
US9180107B2 (en) 2009-03-31 2015-11-10 Nanopharmaceuticals Llc Combination treatment of cancer with cetuximab and tetrac
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
US10201616B2 (en) 2016-06-07 2019-02-12 Nanopharmaceuticals, Llc Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
CA2184002A1 (en) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Method and compositions for increasing the serum half-life of pharmacologically active agents
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
EP1173163B1 (en) * 1999-04-26 2006-06-21 Elliot Danforth, Jr. Pharmaceutical compositions of tetrac and methods of use thereof
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
SE0202886D0 (sv) 2002-10-01
US20050272817A1 (en) 2005-12-08
US20030144359A1 (en) 2003-07-31
DK200201483A (da) 2002-10-03
AU2001235506A1 (en) 2001-10-23
GB0222880D0 (en) 2002-11-13
ES2193003A1 (es) 2003-10-16
NO20024810L (no) 2002-12-06
EP1274416A1 (en) 2003-01-15
GB2377380A (en) 2003-01-15
JP2003530349A (ja) 2003-10-14
FI20000818A0 (fi) 2000-04-06
FI107018B (fi) 2001-05-31
ES2193003B1 (es) 2005-02-01
GB2377380B (en) 2004-07-14
CA2405425A1 (en) 2001-10-18
WO2001076589A1 (en) 2001-10-18
CH695983A5 (de) 2006-11-15
NO20024810D0 (no) 2002-10-04
SE0202886L (sv) 2002-12-02

Similar Documents

Publication Publication Date Title
DE60038200D1 (de) ren Herstellung und Verwendung
FR2799363B1 (fr) Implant medical a meandres en zigzag
IS6779A (is) Mannlíkt mótefni gegn LT-beta-R
EP1250349A4 (en) CARDIAC CELL SPECIFIC ACTIVATORY ELEMENTS AND USES THEREFOR
DE60127551D1 (de) Silikonverbindung und kosmetische zubereitung
DE60221143D1 (de) Brusteinlage enthaltend hautpflegemittel
DE60109968D1 (de) Wegwerfwindel
DE60120890D1 (de) Wegwerfwindel
DE60029737D1 (de) Wegwerfwindel
DE60131102D1 (de) Monofilamentband
DE50106399D1 (de) Chirurgisches element
DE60125492D1 (de) Wegwerfwindel
DE60124963D1 (de) Befestigungsmittel
GB2377380B (en) Dermatological use and a dermatological preparation
DE60119137D1 (de) Gleitelement und herstellungsverfahren dafür
ATE258035T1 (de) Wegwerfartikel für menschliche fäkalien
DE50106596D1 (de) Haftklebemasse und ihre verwendung
DE60105927D1 (de) Wegwerfwindel
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
DE60105232D1 (de) Wegwerfwindel
DE60009219D1 (de) Linearer Reissverschluss
DE60106165D1 (de) Wegwerfwindel
DE60112000D1 (de) Handgelenktotalprothese
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE50105970D1 (de) Verstemmstempel und verwendung desselben

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: HEINO, PEKKA, HELSINKI, FI

8139 Disposal/non-payment of the annual fee